Domov › Intersticiálne ochorenia pľúc › Florida

Klinické štúdie Intersticiálne ochorenia pľúc v štáte Florida

24 štúdií pre Intersticiálne ochorenia pľúc hľadá účastníkov v zariadeniach v štáte Florida.

Mestá v štáte Florida

Oficiálny text štúdie (anglicky)

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

Clinical Research Specialists LLC - Kissimmee, Kissimmee
Lakeland Regional Medical Center - Lakeland, Lakeland
Advanced Pulmonary Research Institute, Loxahatchee Groves
a 4 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT07540988

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

Clinical Research Specialists LLC - Kissimmee, Kissimmee

Prebieha náborFáza 3

Vek 40 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07201922

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

USA017, Gainesville
USA006, Naples
USA026, St. Petersburg
a 1 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT07179380

LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

University of Florida, Gainesville
New Access Research and Medical Services, Miami
Eunix Clinical Research, Orlando
a 1 ďalších

Prebieha náborFáza 2

Vek 18 až 80 · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT05798923

A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)

Clinical Research Site, Kissimmee

Prebieha náborFáza 3

Vek 18 až 85 · Všetky pohlavia · Aktualizované 11. 9. 2026 · NCT07816185

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

GSK Investigational Site, Gainesville
GSK Investigational Site, Naples

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 9. 2026 · NCT06572384

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

GSK Investigational Site, Jacksonville
GSK Investigational Site, Miami

Prebieha náborFáza 2/3

Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 9. 2026 · NCT05878717

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

Cleveland Clinic Florida, Weston

Prebieha náborFáza 2

Vek 40 a viac · Všetky pohlavia · Aktualizované 4. 9. 2026 · NCT06968845

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

AdventHealth Orlando, Orlando

Prebieha nábor

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT06911632

A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

Tampa General Hospital, Tampa

Prebieha náborFáza 3

Vek 18 až 80 · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT07285655

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

Clinical Research Site, Kissimmee

Prebieha náborFáza 2

Vek 18 až 85 · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT07333183

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

University of Florida, Gainesville
NCH Research Institute, Naples
Advent Health Medical Group Advanced Lung Disease, Orlando
a 3 ďalších

Prebieha náborObservačná štúdia

Vek 18 a viac · Všetky pohlavia · Aktualizované 26. 8. 2026 · NCT06388421

Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study

University of Miami Hospital and Clinics, Miami

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 8. 2026 · NCT07486869

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

Mayo Clinic Florida, Jacksonville

Prebieha náborFáza 2/3

Vek 18 až 75 · Všetky pohlavia · Aktualizované 17. 8. 2026 · NCT06328777

An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

USA006, Naples

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 13. 8. 2026 · NCT07234032

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

University of Florida, Gainesville
University of South Florida, Tampa

Prebieha náborObservačná štúdia

Vek 21 a viac · Všetky pohlavia · Aktualizované 12. 8. 2026 · NCT01915511

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

Mayo Clinic of Florida, Jacksonville

Prebieha náborFáza 2

Vek 18 až 80 · Všetky pohlavia · Aktualizované 10. 8. 2026 · NCT07175038

Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease

University of South Florida, Tampa

Prebieha náborFáza 2

Vek 4 a viac · Všetky pohlavia · Aktualizované 22. 7. 2026 · NCT04925375

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

Ascension Medical Group St. Vincent's Lung Institute, Jacksonville
Mayo Clinic, Jacksonville
TGH/USF Center for Advanced Lung Disease and Lung Transplant, Tampa
a 1 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 13. 7. 2026 · NCT05943535

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

Advent Health, Orlando
Tampa General Hospital Center of Research Excellence, Tampa

Prebieha náborObservačná štúdia

Vek 18 až 80 · Všetky pohlavia · Aktualizované 26. 6. 2026 · NCT06129240

Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease

Mayo Clinic in Florida, Jacksonville

Prebieha nábor

Vek 18 a viac · Všetky pohlavia · Aktualizované 20. 3. 2026 · NCT06751069

Nebulized Human Amniotic Fluid in Patients With Interstitial Lung Disease

Maule Stem Cell Research Institute, Venice

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 1. 2026 · NCT07372989

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

Florida Lung Asthma and Sleep Specialist, Celebration
Central Florida Pulmonary Group, P.A. (CFPG) - Downtown Orlando, Orlando

Prebieha náborFáza 2

Vek 40 a viac · Všetky pohlavia · Aktualizované 12. 11. 2025 · NCT05975983

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

aTyr Investigative Site, Miami

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 7. 5. 2025 · NCT05892614

Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.